Nasdaq Markets

InvestorPlace - Stock Market News, Stock Advice & Trading Tips

The momentum in the U.S. housing market seems to be returning and some encouraging data sets are emerging from the sector. The May data on U.S. housing starts and building permits reflect improvements in U.S. homebuilding. According to the Commerce Department, housing starts jum

(RTTNews) - U.S. stocks tumbled into the red around noon, failing to hold strong early gains, and despite a couple of attempts to rebound into positive territory, ended on a weak note on Friday.

Gaming and Leisure Properties (NASDAQ: GLPI) will soon see its coffers swell. The casino-focused real estate investment trust (REIT) announced that it is floating $500 million worth of senior unsecured notes in a public offering that's expected to close on Thursday, June 25.

Despite marking triple-digit gains early in the day, the Dow fell once again, finishing 200 points lower after a plethora of headlines concerning a resurgence in coronavirus cases stoked fears among investors. Meanwhile, the S&P 500 also lost ground to finish the day lower

Investors were not expecting to hear much good news from CarMax's (NYSE: KMX) fiscal 2021 first-quarter earnings report. That period covers March, April, and May -- three months capturing the most intense impact to date from the COVID-19 pandemic that kept most of its automotive

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which

In trading on Friday, shares of Osisko Gold Royalties Ltd (Symbol: OR) crossed above their 200 day moving average of $9.29, changing hands as high as $9.63 per share. Osisko Gold Royalties Ltd shares are currently trading up about 6.2% on the day. The chart below shows the o

In trading on Friday, shares of Easterly Government Properties Inc (Symbol: DEA) crossed below their 200 day moving average of $23.71, changing hands as low as $23.46 per share. Easterly Government Properties Inc shares are currently trading off about 1.9% on the day. The ch

In trading on Friday, shares of VMware Inc (Symbol: VMW) crossed above their 200 day moving average of $144.31, changing hands as high as $152.00 per share. VMware Inc shares are currently trading up about 3.6% on the day. The chart below shows the one year performance of VM

In a late-breaking, mid-afternoon announcement, the Cruise Lines International Association (CLIA), the trade association that represents all of the major cruise lines -- and more relevantly, all of the blue-chip cruise line brands owned by publicly traded Carnival Corporation (N

American Airlines Group (NASDAQ: AAL) is preparing to float $2 billion in junk bonds next week, hoping to shore up its balance sheet against the dangers of a drawn-out recession, reports Bloomberg.  

Image source: The Motley Fool.

Datadog (NASDAQ: DDOG) announced on Thursday that it had successfully navigated the Federal Risk and Authorization Management Program (FedRAMP) certification process and has achieved its Low-Impact Software-as-a Service (SaaS) Authorization.

It’s tough to get growth and value in the same investment during normal times, but it was practically impossible when stocks were plunging during the worst of the pandemic.But the indices have had a remarkable bounce-back since late March, and now its time to start looking for

InvestorPlace - Stock Market News, Stock Advice & Trading Tips

InvestorPlace - Stock Market News, Stock Advice & Trading Tips

Momentum is picking up for diabetes-focused biotech MannKind (MNKD). Shares surged 36% this week after MannKind’s presentation at the American Diabetes Association's conference revealed some promising data for its inhaled insulin device, Afrezza.

Data from a switching study demonstrated that when patients with type 2 diabetes converted to Afrezza from a mealtime injected insulin, there was a notable (0.8%) drop in A1C (hemoglobin) levels after 14-weeks. Patients’ quality of life improved, too.

Additionally, four studies of patients with type 1 diabetes showed Afrezza can be effectively dosed at 1.5x to 2x the level of injected mealtime insulin, without raising any safety concerns.

The company also presented data from two Phase 3 studies which showed that treatment with Afrezza can result in less weight gain (at 52 weeks) as well as modest weight loss (at 26 weeks).

From a commercial perspective, a presentation highlighting Afrezza’s safety profile and advantages in front of an industry crowd could sow confidence in the product among physicians, which in turn, could lead to more sales.

BTIG analyst Robert Hazlett estimates Afrezza can achieve peak US sales of more than $400 million. Additionally, the 5-star analyst believes the data “reinforces positive Afrezza characteristics,” and that the device can “play a material role in diabetes management.”

Hazlett further said, “We believe Afrezza's differentiated PK/PD profile can lead to improved safety, time in range, and even HbA1c, important metrics of glucose control for those with diabetes. We expect MannKind to generate increased physician awareness and demand for Afrezza through its revived focus on publishing data showing how to optimize Afrezza use.”

To this end, Hazlett maintained a Buy rating on MannKind along with a $4 price target. The implication for investors? Upside potential of a strong 107%. (To watch Hazlett’s track record, click here)

MNKD also has the Street’s backing. All three analysts that have reviewed the diabetes specialist over the past three months reached the same conclusion: Buy. MNKD's Strong Buy consensus rating is tagged with a $3 average price target, indicating there is room for a possible 61% uptick over the next 12 months. (See MannKind stock-price forecast on TipRanks)

To find good ideas for healthcare stocks trading at attractive valuations, visit TipRanks’ Best Stocks to Buy, a newly launched tool that unites all of TipRanks’ equity insights.

Friday morning brought another relatively calm session to Wall Street, as major market benchmarks were generally higher but by modest amounts. Market participants are trying to be patient in seeing whether the recovery from the worst of the coronavirus pandemic will continue or

BMW (OTC: BMWYY) and Mercedes-Benz are shutting down their joint self-driving effort, at least for the moment — though they might work together again in the future.